Who owns GALECTIN THERAPEUTICS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GALT from SEC Form 13F filings across 98 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 98 institutions disclosed 15.6M shares of GALECTIN THERAPEUTICS INC worth $72.2M — about 23.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
98
13F holders
$72.2M
value, 2026 filers
23.7%
of shares outstanding (15.6M sh)
21
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of GALT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.0M | $13.9M | 0.0% | 4.5% | +273.9% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $10.1M | 0.0% | 3.3% | +10.2% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $6.1M | 0.0% | 2% | +113.5% |
| 4 | OSAIC HOLDINGS, INC. | 1.2M | $5.6M | 0.0% | 1.8% | +7.2% |
| 5 | MARSHALL WACE, LLP | 831,010 | $3.9M | 0.0% | 1.3% | -31.9% |
| 6 | Wealthspire Advisors, LLC | 721,788 | $3.3M | 0.0% | 1.1% | 0.0% |
| 7 | STATE STREET CORP | 567,779 | $2.6M | 0.0% | 0.9% | +119.7% |
| 8 | COMMONWEALTH EQUITY SERVICES, LLC | 407,113 | $1.9M | 0.0% | 0.6% | +10.9% |
| 9 | NORTHERN TRUST CORP | 386,545 | $1.8M | 0.0% | 0.6% | +196.3% |
| 10 | VANGUARD FIDUCIARY TRUST CO | 366,476 | $1.7M | 0.0% | 0.6% | +20.5% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 327,766 | $1.5M | 0.0% | 0.5% | new |
| 12 | TWO SIGMA INVESTMENTS, LP | 318,245 | $1.5M | 0.0% | 0.5% | -31.9% |
| 13 | LPL Financial LLC | 285,380 | $1.3M | 0.0% | 0.4% | +6.8% |
| 14 | Sovran Advisors, LLC | 257,997 | $874,610 | 0.1% | 0.4% | +0.1% |
| 15 | Geneos Wealth Management Inc. | 240,427 | $1.1M | 0.0% | 0.4% | -0.2% |
| 16 | UBS Group AG | 219,319 | $1.0M | 0.0% | 0.3% | +22.0% |
| 17 | RETIREMENT GUYS FORMULA LLC | 211,053 | $979,286 | 0.4% | 0.3% | +12.8% |
| 18 | CITADEL ADVISORS LLC | 198,701 | $921,973 | 0.0% | 0.3% | -31.6% |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 177,197 | $822,194 | 0.0% | 0.3% | -68.1% |
| 20 | NATIONAL BANK OF CANADA /FI/NEW | 167,900 | $779,056 | 0.0% | 0.3% | new |
| 21 | BLAIR WILLIAM & CO/IL | 149,283 | $692,673 | 0.0% | 0.2% | 0.0% |
| 22 | Cambridge Investment Research Advisors, Inc. | 130,648 | $606,000 | 0.0% | 0.2% | +1.6% |
| 23 | GSA CAPITAL PARTNERS LLP | 128,664 | $597,000 | 0.0% | 0.2% | +80.1% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 116,424 | $540,207 | 0.0% | 0.2% | +288.0% |
| 25 | Bank of New York Mellon CorpNEW | 105,742 | $490,644 | 0.0% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.